SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hawley, C.J.
Right arrow Articles by Walker, M.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hawley, C.J.
Right arrow Articles by Walker, M.H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Tolerability of combined treatment with lithium and paroxetine: 19 cases treated under open conditions

C.J. Hawley

Consultant in Psychological Medicine, Queen Elizabeth Hospital, Howlands, Welwyn Garden City, Hertfordshire AL7 4QH

A.G. Roberts

Academic Department of Psychiatry, St Mary's Hospital Medical School, Praed Street, Paddington, London W2 1NY, UK

M.H. Walker

Academic Department of Psychiatry, St Mary's Hospital Medical School, Praed Street, Paddington, London W2 1NY, UK

Nineteen patients resistant to paroxetine monotherapy were treated by lithium augmentation for 6 weeks to assess tolerability. Although the addition of lithium increased the number of adverse events, none were serious. The combination of lithium and paroxetine is safe enough to warrant further investigation as a treatment for resistant depression.

Key Words: paroxetine • lithium • combination • augmentation • safety

Journal of Psychopharmacology, Vol. 8, No. 4, 266-267 (1994)
DOI: 10.1177/026988119400800412
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
C.J. Hawley, S. Ratnam, H.A. Pattinson, S.J. Quick, and D. Echlin
Safety and tolerability of combined treatment with moclobemide and SSRIs: a preliminary study of 19 patients
J Psychopharmacol, January 1, 1996; 10(3): 241 - 245.
[Abstract] [PDF]


Advertisement